Diabetes decisions — 2026

The Veteran's TDIU claim for the period beginning October 19, 2015 is dismissed as moot due to his receipt of a maximum benefit award under SMC.,For the period prior to October 19, 2015, the Veteran's service-connected diabetes mellitus and diabetic nephropathy did not render him unable to secure or follow a substantially gainful occupation.

The Board has restored service connection for diabetes mellitus and coronary artery disease (CAD) s/p CABG, myocardial infarction, congestive heart failure with heart block. Service connection was previously severed due to a lack of evidence confirming herbicide exposure during the Veteran's period in Korea.

The Veteran's service connection claims for hyperlipidemia, gastroesophageal reflux disease (GERD), and diabetes mellitus, type II as secondary to obstructive sleep apnea are dismissed. The Veteran's service connection claim for obstructive sleep apnea is granted.

The Board has dismissed the appeal due to the appellant's withdrawal of his claims.

The Board denied service connection for heart disorder, hypertension, and diabetes mellitus type II as the Veteran did not serve in Vietnam or near its coastlines, nor was he exposed to herbicide agents. The Board also found no evidence of exposure to contaminated water at Camp Lejeune.

The Board has dismissed the claims as there was no valid appeal to review.

The Board has granted service connection for diabetes mellitus type II and an acquired psychiatric disorder (PTSD with recurrent major depressive disorder). The deferred claim for chronic eczematous dermatitis is dismissed due to lack of appellate jurisdiction.

The Veteran's service-connected Parkinson's disease, diabetes, heart disability, and bilateral lower extremity neuropathy have rendered him in need of regular aid and attendance. The Board has granted special monthly compensation based on the need for regular aid and attendance.

The Veteran's service-connected hypertension is denied as the evidence does not show diastolic pressure predominantly 100 or more, systolic pressure predominantly 160 or more, or continuous medication with a history of diastolic pressure predominantly 100 or more.,The Veteran's service-connected PTSD is denied as the evidence does not show total occupational and social impairment.

The Veteran's appeal has been dismissed due to their death during the pendency of the appeal.

The Veteran's claims for diabetes mellitus type II, prostate cancer, and erectile dysfunction have been granted effective June 2, 2021.,An earlier effective date is not warranted as the claims were previously denied in April 2018.

The Board denied the Veteran's claim for service connection for type II diabetes mellitus, finding that it was not related to his military service or any incident of service origin.

The Veteran's claim for service connection for allergic rhinitis was granted with an effective date of August 10, 2022. The claims for obesity, hypertension, OSA, diabetes mellitus, and atopic dermatitis with tinea versicolor are remanded due to the need for further evaluation.

The Veteran's claims for service connection for diabetes mellitus, type II, hypertension, and Parkinson's disease are being remanded due to new evidence received since the prior decisions.

The Veteran's appeals for earlier effective dates were dismissed as he withdrew his claims prior to the Board hearing.

The Board has denied service connection for diabetes mellitus and remanded the tinnitus claim due to inadequate medical nexus opinions. The Veteran's diabetes mellitus claim is denied as there is no evidence of a relationship between his current condition and service.

The Board has remanded the claims for type II diabetes mellitus due to in-service exposure to contaminated water supply at Marine Corps Air Station New River, North Carolina and exposure to jet fuel. The Veteran's hyperlipidemia claim is denied as it does not meet the criteria for a current disability.

The Veteran's initial ratings for diabetic peripheral neuropathy of the upper and lower extremities have been denied as they do not meet the criteria for higher ratings.

The Board has denied service connection for diabetes, hearing loss, and hypertension. The effective dates for CAD have also been denied.,The Veteran's claims for increased evaluations of hypertension and CAD are remanded, as is the claim for TDIU.

The Board has granted an initial rating of 80 percent for left lower extremity diabetic peripheral neuropathy, effective from October 3, 2025.